Science & Medicine:Medicine
Where to now? AVERT answered an important question, but raised many more
The AVERT trial was a Phase 3 randomised trial with over 2100 subjects designed to end the controversy about the early mobilisation of stroke patients. It sounds intuitive doesn’t it, if a patient has a stroke get them up and moving as soon as possible get the blood flowing and consequently the patient healing faster.
But this wasn’t the case, and the stroke community, especially the rehab and recovery arm were collectively shocked by the results which indicated that early mobilization may actually cause harm.
Undoubtedly this ultimately successful trial answered an important clinical question, opening the door for more large scale rehab and recovery trials.
Now the priority questions are: (1) What is the optimal dose in minutes of VEM in duration and frequency? (2) How intense should the exertion be? (3) How should we design trials that compare different specified doses for different subgroups?
I’m Carmen Lahiff-Jenkins Managing Editor of the International Journal of Stroke and I spoke to Mark Bayley author of Where to now? AVERT answered an important question, but raised many more recently published in the International Journal of Stroke.
Cerebral microbleeds: beyond the microscope. Vincent Berezowski
Prof. Rustam Al-Shahi Salman REstart or STop Antithrombotics Randomised Trial for oral anticoagulants
Drs. Shelia Martins and Raul Nogueira RESILIENT trial
Prof. Julie Berhardt in conversation with Dr. Vivian Fu TACAS trial ESOC
ESOC Prof. Helen Rodgers Ratuls Trial
Craig Anderson ENCHANTED results from the ISC
Excess stroke incidence in young Aboriginal people in South Australia: pooled results from two population-based studies: Anna Balabanski
Post-stroke infections and preventive antibiotics in stroke: update of clinical evidence - Jan-Dirk Vermeij
Systematic Review Of Organizational Models For Intra-Arterial Treatment Of Acute Ischemic Stroke
Erin Godeke - trial results from VERSE
Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis
Prof.Stephen Davis in conversation with Maynak Goyal SSA/Smartstrokes
Janice Eng in conversation with Carmen Lahiff-Jenkins SSA/Smartstrokes 2018
Prof. Avril Drummond in conversation with Prof. Richard Lindley
Breaking Up Sitting Time after Stroke (BUST-Stroke) - Coralie English
Sedentary behaviour after stroke: a new target for therapeutic intervention: Sarah Morton
Johanna Ralston from the World Obesity Society
Infarct location is associated with quality of life after mild ischemic stroke: Chen Lin
The Brain Health Index: Towards a combined measure of neurovascular and neurodegenerative structural brain injury with David Dickie
Computed tomographic angiography in stroke and high-risk transient ischemic attack: Do not leave the emergency department without it!: Brett R Graham
This Podcast Will Kill You
The Peter Attia Drive
The Curbsiders Internal Medicine Podcast
Medgeeks Clinical Review Podcast
Code and preview